SCHEMBL2914099

SCHEMBL2914099

CCCC(=O)N(c1ccc(NC(=O)c2cc(N3C(=O)CCNC3=O)cc(C(C)(C)C)c2OC)cc1)S(C)(=O)=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.35
MAPT P10636 8/20 0.34
HSD17B10 Q99714 3/20 0.34
TSHR P16473 1/20 0.34
KDM4E B2RXH2 4/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
USP2 O75604 2/20 0.33
BCL2 P10415 1/20 0.33
ALDH1A1 P00352 7/20 0.32
NPSR1 Q6W5P4 3/20 0.32
TP53 P04637 2/20 0.32
LMNA P02545 1/20 0.32
HTT P42858 2/20 0.31
ITGA4 P13612 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
CRBN Q96SW2 1/20 0.31
PDE10A Q9Y233 1/20 0.31
HPGD P15428 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2907867 0.94 NR1H4 (0.35) NR1H4MAPTHSD17B10TSHRKDM4E
SCHEMBL2910166 0.91 MAPT (0.36) NR1H4MAPTHSD17B10TSHRKDM4E
SCHEMBL2907495 0.89 NR1H4 (0.36) NR1H4MAPTHSD17B10TSHRKDM4E
SCHEMBL2915395 0.88 BCL2 (0.36) NR1H4MAPTHSD17B10TSHRKDM4E
SCHEMBL2907607 0.87 MAPT (0.34) NR1H4MAPTHSD17B10TSHRKDM4E
SCHEMBL15654048 0.86 BCL2 (0.34) NR1H4MAPTHSD17B10TSHRKDM4E
SCHEMBL2907218 0.85 NR1H4 (0.38) NR1H4MAPTHSD17B10TSHRKDM4E
SCHEMBL2913231 0.84 MAPT (0.34) NR1H4MAPTHSD17B10TSHRKDM4E
SCHEMBL2907827 0.84 LMNA (0.46) NR1H4MAPTHSD17B10TSHRKDM4E
SCHEMBL2907824 0.84 MAPT (0.39) NR1H4MAPTHSD17B10TSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222646-A1 URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C Abbott Laboratories (US) 2010-09-01 EP disclosed
WO-2009039127-A1 URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C ABBOTT LABORATORIES (US) 2009-03-26 WO disclosed